KDIGO (Kidney Disease: Improving Global Outcomes) criteria could be a useful outcome predictor of cisplatin-induced acute kidney injury

Oncology (Switzerland)

Volumn 82, Issue 6, 2012, Pages 354-359

  Mizuno, Tomohiro ^a,b   Sato, Waichi ^c   Ishikawa, Kazuhiro ^a   Shinjo, Hibiki ^c   Miyagawa, Yasuhiro ^a   Noda, Yukihiro ^b   Imai, Enyu ^c   Yamada, Kiyofumi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute kidney injury; Cisplatin; Kidney Disease: Improving Global Outcomes criteria; Serum creatinine

Indexed keywords

BLEOMYCIN; CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; GIMERACIL; IRINOTECAN; METHOTREXATE; NAVELBINE; NIMUSTINE; OTERACIL; TAMOXIFEN; TEGAFUR; VINBLASTINE;

ACUTE KIDNEY FAILURE; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLADDER CANCER; CLINICAL ASSESSMENT TOOL; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; JAPANESE; KIDNEY DISEASE IMPROVING GLOBAL OUTCOME CRITERIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OUTCOME ASSESSMENT; OVARY CANCER; OVERALL SURVIVAL; PARANASAL SINUS CANCER; PELVIS CANCER; PHARYNX CANCER; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RECTUM CANCER; STOMACH CANCER; TESTIS CANCER; UTERINE CERVIX CANCER;

ACUTE KIDNEY INJURY; ANTINEOPLASTIC AGENTS; CISPLATIN; COHORT STUDIES; CREATININE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 84862494293     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000338664     Document Type: Article

References (16)

1. Lamiere N, Van Biesen W, Vanholder R: Acute renal failure. Lancet 2005; 365: 417-430. (Pubitemid 40179230)
2. Esson ML, Schrier RW: Diagnosis and treatment of acute tubular necrosis. Ann Intern Med 2002; 137: 744-752. (Pubitemid 35265319)
3. Bellomo R, Ronco C, Kellum JA, et al: Acute renal failure definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: 204-212.
4. Mehta RL, Kellum JA, Shah SV, et al: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: 31.
5. Cruz DN, Bolgan I, Perazella MA, et al: North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE criteria. Clin J Am Soc Nephrol 2007; 2: 418-425.
6. Fonseca Ruiz NJ, Castro DP, Guerra AM, et al: Renal injury study in critical ill patients in accordance with the new definition given by the Acute Kidney Injury Network. J Crit Care 2011; 26: 206-212.
7. Ho J, Reslerova M, Gali B, et al: Serum creatinine measurement immediately after cardiac surgery and prediction of acute kidney injury. Am J Kidney Dis 2012; 59: 196-201.
8. Madias NE, Harrington JT: Platinium nephrotoxicity. Am J Med 1978; 65: 307-314.
9. Goldstein RS, Mayor GH: Minireview: the nephrotoxicity of cisplatin. Life Sci 1983; 32: 685-690.
10. Numico G, Benasso M, Vannozzi MO, et al: Hydration regimen and hematological toxicity of a cisplatin-based chemotherapy regimen. Clinical observations and pharmacokinetic analysis. Anticancer Res 1998; 18: 1313-1318. (Pubitemid 28234037)
11. Matsuo S, Imai E, Horio M, et al: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
12. Taguchi T, Nazneen A, Abid MR, Razzaque MS: Cisplatin associated nephrotoxicity and pathological events. Contrib Nephrol 2005; 148: 107-121. (Pubitemid 43264925)
13. Arany I, Safirstein RL: Cisplatin nephrotoxicity. Semin Nephrol 2003; 23: 460-464. (Pubitemid 37176691)
14. Launay-Vacher V, Rey JB, Isnard-Bagnis C, Deray G, Daouphars M: Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer Chemother Pharmacol 2008; 61: 903-909.
15. Hsu CY, Ordonez JD, Chertow GM, et al: The risk of acute renal failure in patients with chronic kidney disease. Kidney Int 2008; 74: 101-107. (Pubitemid 351841887)
16. Chertow GM, Soroko SH, Paganini EP, et al: Mortality after acute renal failure: Models for prognostic stratification and risk adjustment. Kidney Int 2006; 70: 1120-1126. (Pubitemid 44344083)